Klacid Pro

Clarithromycin, the active ingredient in Klacid Pro, is a macrolide antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections, particularly in the respiratory tract, skin, and soft tissues, and is prescribed for adults and children when indicated by a healthcare professional.

GNH USA supplies Klacid Pro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions.

Clarithromycin is used to treat bacterial infections affecting the respiratory tract, ears, skin, and certain gastrointestinal conditions.

- Community-acquired pneumonia: effective against typical and atypical pathogens, helping resolve lung infection. - Acute bacterial sinusitis: reduces sinus inflammation and bacterial load, improving nasal drainage. - Acute exacerbations of chronic bronchitis: shortens illness duration and improves breathing function. - Skin and soft‑tissue infections: targets Staphylococcus and Streptococcus species, promoting wound healing. - Helicobacter pylori eradication (in combination therapy): contributes to ulcer healing by eliminating the bacterium.

Clarithromycin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: upset stomach often occurring shortly after dosing. - Diarrhea: loose stools that may be mild to moderate. - Abdominal pain: cramping or discomfort in the stomach area. - Taste disturbance: altered or metallic taste perception. - Headache: mild to moderate head pain. - Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - QT interval prolongation: potential heart rhythm disturbances. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Clostridioides difficile colitis: severe intestinal infection. - Stevens‑Johnson syndrome: rare but serious skin reaction. - Anaphylaxis: life‑threatening hypersensitivity response.

Before prescribing clarithromycin, clinicians should consider several safety factors.

- Assess renal and hepatic function: adjust therapy if impairment present. - Avoid use in patients with known macrolide hypersensitivity: may trigger allergic reactions. - Monitor cardiac status: risk of QT interval prolongation, especially with other QT‑prolonging drugs. - Use caution in pregnancy and lactation: benefits must outweigh potential risks. - Consider drug interactions: review concomitant medications for CYP3A4 substrates. - Store at ambient temperature: keep below 25°C, in original container, protect from moisture and light.

Clarithromycin interacts with several medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Cisapride: may cause serious cardiac arrhythmias. - Pimozide: increased risk of QT prolongation and cardiac events. - Statins metabolized by CYP3A4 (e.g., simvastatin, lovastatin): risk of myopathy.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Theophylline: may increase serum concentrations, necessitating dose adjustment.